CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
intermediate cervical plexus block ropivacaine +3 moredrug
Likely dose
intermediate cervical plexus block ropivacaine 20mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02336958
NCT02336958N/ACompleted
CompareCT.gov

Ultrasound Guided Intermediate Cervical Plexus Block -Randomized Evaluation Concerning the Significance of Additional Perivascular Local Anesthetic Infiltration

Helios Research Center·interventional·Posted Jan 13, 2015·Updated Mar 23, 2015

In Brief

A clinical study evaluating intermediate cervical plexus block ropivacaine, pericarotidal infiltration (active comparator) ropivacaine, and 2 other interventions for Carotid Stenosis. Completed, enrolled 40 participants.

Detailed Summary

For ultrasound guided intermediate cervical plexus block this randomized comparison is testing the hypothesis, that an additional perivascular infiltration is associated with increased block quality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarotid Stenosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 13, 2015
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.5 years ago

Interventions

intermediate cervical plexus block ropivacainedrug

20ml ultrasound guided intermediate cervical plexus block.

pericarotidal infiltration (active comparator) ropivacainedrug

5ml ropivacaine 0.75% (active comparator): pericarotidal infiltration.

jugular infiltration prilocainedrug

5ml prilocaine 1% jugular infiltration for wound drainage.

pericarotidal infiltration (placebo comparator) salinedrug

5ml saline 0.9% (placebo comparator): pericarotidal infiltration.